Analysis of sphingolipid and prostaglandin synthesis during zymosan-induced inflammation

Prostaglandins and Other Lipid Mediators

Volumn 99, Issue 1-2, 2012, Pages 15-23

  Linke, Bona ^a   Schreiber, Yannick ^a   Zhang, Dong Dong ^a   Pierre, Sandra ^a   Coste, Ovidiu ^a   Henke, Marina ^a   Suo, Jing ^a   Fuchs, Judith ^a   Angioni, Carlo ^a   Ferreiros Bouzas, Nerea ^a   Geisslinger, Gerd ^a   Scholich, Klaus ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Cyclooxygenase 2; Inflammation; Prostaglandin; Sphingosine kinase; Sphingosine 1 phosphate; Zymosan

Indexed keywords

CYCLOOXYGENASE 2; DICLOFENAC; PROSTAGLANDIN; PROSTANOID; SPHINGOLIPID; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CELL ISOLATION; CONTROLLED STUDY; EDEMA; ENZYME SYNTHESIS; INFLAMMATION; KNOCKOUT MOUSE; LIPOGENESIS; MOUSE; NOCICEPTION; NONHUMAN; PAW EDEMA; PROSTAGLANDIN SYNTHESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SPHINGOLIPID SYNTHESIS;

ANIMALS; CYCLOOXYGENASE 2; EDEMA; INFLAMMATION; LYSOPHOSPHOLIPIDS; MICE; MICE, KNOCKOUT; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROSTAGLANDINS; SPHINGOSINE; ZYMOSAN;

EID: 84865514929     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2012.06.002     Document Type: Article

References (52)

1. K. Scholich, and G. Geisslinger Is mPGES-1 a promising target for pain therapy? Trends Pharmacol Sci 27 2006 399 401
2. C. Brenneis, O. Coste, and K. Altenrath Anti-inflammatory role of microsomal prostaglandin E synthase-1 in a model of neuroinflammation J Biol Chem 286 2011 2331 2342
3. C. Brenneis, T.J. Maier, and R. Schmidt Inhibition of prostaglandin E2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition FASEB J 20 2006 1352 1360
4. M. Narita, M. Shimamura, and S. Imai Role of interleukin-1beta and tumor necrosis factor-alpha-dependent expression of cyclooxygenase-2 mRNA in thermal hyperalgesia induced by chronic inflammation in mice Neuroscience 152 2008 477 486
5. G.A. FitzGerald, and C. Patrono The coxibs, selective inhibitors of cyclooxygenase-2 N Engl J Med 345 2001 433 442
6. G.A. Fitzgerald Coxibs and cardiovascular disease N Engl J Med 351 2004 1709 1711
7. S. Pierre, T. Eschenhagen, G. Geisslinger, and K. Scholich Capturing adenylyl cyclases as potential drug targets Nat Rev Drug Discov 8 2009 321 335
8. K. Brune, B. Renner, and B. Hinz Using pharmacokinetic principles to optimize pain therapy Nat Rev Rheumatol 6 2010 589 598
9. A.E. Alewijnse, and S.L. Peters Sphingolipid signalling in the cardiovascular system: good, bad or both? Eur J Pharmacol 585 2008 292 302
10. O. Coste, C. Brenneis, and B. Linke Sphingosine 1-phosphate modulates spinal nociceptive processing J Biol Chem 283 2008 32442 32451
11. V. Brinkmann, J.G. Cyster, and T. Hla FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function Am J Transplant 4 2004 1019 1025
12. S. Spiegel, and S. Milstien The outs and the ins of sphingosine-1- phosphate in immunity Nat Rev Immunol 11 2011 403 415
13. H. Rosen, P.J. Gonzalez-Cabrera, M.G. Sanna, and S. Brown Sphingosine 1-phosphate receptor signaling Annu Rev Biochem 78 2009 743 768
14. J.D. Saba, and T. Hla Point-counterpoint of sphingosine 1-phosphate metabolism Circ Res 94 2004 724 734
15. B. Anliker, and J. Chun Lysophospholipid G protein-coupled receptors J Biol Chem 279 2004 20555 20558
16. S. Spiegel, and S. Milstien Sphingosine-1-phosphate: an enigmatic signalling lipid Nat Rev Mol Cell Biol 4 2003 397 407
17. H. Chi Sphingosine-1-phosphate and immune regulation: trafficking and beyond Trends Pharmacol Sci 32 2011 16 24
18. A. Skoura, T. Sanchez, K. Claffey, S.M. Mandala, R.L. Proia, and T. Hla Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina J Clin Invest 117 2007 2506 2516
19. A.M. Johann, A. Weigert, and W. Eberhardt Apoptotic cell-derived sphingosine-1-phosphate promotes HuR-dependent cyclooxygenase-2 mRNA stabilization and protein expression J Immunol 180 2008 1239 1248
20. A.J. Snider, T. Kawamori, and S.G. Bradshaw A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis FASEB J 23 2009 143 152
21. B.J. Pettus, J. Bielawski, and A.M. Porcelli The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha FASEB J 17 2003 1411 1421
22. J. Davaille, C. Gallois, and A. Habib Antiproliferative properties of sphingosine 1-phosphate in human hepatic myofibroblasts. A cyclooxygenase-2 mediated pathway J Biol Chem 275 2000 34628 34633
23. S. Mandala, R. Hajdu, and J. Bergstrom Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists Science 296 2002 346 349
24. P. Keul, S. Lucke, and K. von Wnuck Lipinski Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis Circ Res 108 2010 314 323
25. J. Michaud, D.S. Im, and T. Hla Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation J Immunol 184 2010 1475 1483
26. B. Zemann, N. Urtz, and R. Reuschel Normal neutrophil functions in sphingosine kinase type 1 and 2 knockout mice Immunol Lett 109 2007 56 63
27. B. Zemann, B. Kinzel, and M. Muller Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720 Blood 107 2006 1454 1458
28. A. Hofacker, O. Coste, H.V. Nguyen, C. Marian, K. Scholich, and G. Geisslinger Downregulation of cytosolic prostaglandin E2 synthase results in decreased nociceptive behavior in rats J Neurosci 25 2005 9005 9009
29. H. Schmidt, R. Schmidt, and G. Geisslinger LC-MS/MS-analysis of sphingosine-1-phosphate and related compounds in plasma samples Prostaglandins Other Lipid Mediat 81 2006 162 170
30. O. Coste, S. Pierre, and C. Marian Antinociceptive activity of the S1P-receptor agonist FTY720 J Cell Mol Med 12 2008 995 1004
31. Y. Yatomi Plasma sphingosine 1-phosphate metabolism and analysis Biochim Biophys Acta 1780 2008 606 611
32. W. Jessup Lipid metabolism: sources and stability of plasma sphingosine-1-phosphate Curr Opin Lipidol 19 2008 543 544
33. R. Pappu, S.R. Schwab, and I. Cornelissen Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate Science 316 2007 295 298
34. K. Venkataraman, Y.M. Lee, and J. Michaud Vascular endothelium as a contributor of plasma sphingosine 1-phosphate Circ Res 102 2008 669 676
35. Heart disease and stroke statistics - 2008 update 2008 American Heart Association
36. S.C. Sensken, C. Bode, M. Nagarajan, U. Peest, O. Pabst, and M.H. Graler Redistribution of sphingosine 1-phosphate by sphingosine kinase 2 contributes to lymphopenia J Immunol 184 2010 4133 4142
37. L. Zhi, B.P. Leung, and A.J. Melendez Sphingosine kinase 1 regulates pro-inflammatory responses triggered by TNFalpha in primary human monocytes J Cell Physiol 208 2006 109 115
38. A. Billich, F. Bornancin, D. Mechtcheriakova, F. Natt, D. Huesken, and T. Baumruker Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators Cell Signal 17 2005 1203 1217
39. A.J. Snider, K.A. Orr Gandy, and L.M. Obeid Sphingosine kinase: role in regulation of bioactive sphingolipid mediators in inflammation Biochimie 92 2010 707 715
40. C. Brenneis, O. Coste, and R. Schmidt Consequences of altered eicosanoid patterns for nociceptive processing in mPGES-1-deficient mice J Cell Mol Med 12 2008 639 648
41. L. Yang, Y. Yatomi, Y. Miura, K. Satoh, and Y. Ozaki Metabolism and functional effects of sphingolipids in blood cells Br J Haematol 107 1999 282 293
42. J. Michaud, M. Kohno, R.L. Proia, and T. Hla Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice FEBS Lett 580 2006 4607 4612
43. F. Roviezzo, V. Brancaleone, and L. De Gruttola Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo J Pharmacol Exp Ther 337 2011 830 837
44. L.W. Maines, L.R. Fitzpatrick, and K.J. French Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase Dig Dis Sci 53 2008 997 1012
45. Y. Edmonds, S. Milstien, and S. Spiegel Development of small-molecule inhibitors of sphingosine-1-phosphate signaling Pharmacol Ther 132 2011 352 360
46. S. Pyne, R. Bittman, and N.J. Pyne Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules Cancer Res 71 2011 6576 6582
47. G.J. Patti, O. Yanes, and L.P. Shriver Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin Nat Chem Biol 8 2012 232 234
48. C. Habrukowich, D.K. Han, and A. Le Sphingosine interaction with acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) regulates PP2A activity and cyclooxygenase (COX)-2 expression in human endothelial cells J Biol Chem 285 2010 26825 26831
49. N. Mair, C. Benetti, and M. Andratsch Genetic evidence for involvement of neuronally expressed S1P receptor in nociceptor sensitization and inflammatory pain PLoS One 6 2011 e17268
50. T. Doyle, A. Finley, Z. Chen, and D. Salvemini Role for peroxynitrite in sphingosine-1-phosphate-induced hyperalgesia in rats Pain 152 2011 643 648
51. L. Kappos, E.W. Radue, and P. O'Connor A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis N Engl J Med 362 2010 387 401
52. J.A. Cohen, F. Barkhof, and G. Comi Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis N Engl J Med 362 2010 402 415